Lifetime Costs of Hospitalised Cardiovascular Disease in Australia: An Incidence-Based Estimate

Loading...
Thumbnail Image
File version

Accepted Manuscript (AM)

Author(s)
Nghiem, Son
Afoakwah, Clifford
Byrnes, Joshua
Scuffham, Paul
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2021
Size
File type(s)
Location
Abstract

Objectives To estimate the incidence-based, lifetime costs of health care and productivity losses associated with cardiovascular disease (CVD) using hospital admission data from Queensland, Australia.

Methods Retrospective analysis of data on CVD health care use sourced from Queensland Hospital Admitted Patient Data Collection (QHAPDC), Emergency Department Data Collection (EDDC), Medicare Benefits Schedule (MBS) and the Pharmaceutical Benefits Scheme (PBS). Costs were estimated from the societal perspective.

Study participants included patients who were first admitted to any Queensland hospital in 2010 for a CVD-related treatment. Subsequent admissions of these patients were followed until December 2015. The present value of incidence-based lifetime costs per patient were used to estimate the total costs for Australia. All costs were presented in Australian dollars at 2019 prices.

Results The estimated lifetime health care cost of CVD was $65,700 per person. Productivity loss cost was higher at $75,200 per person, and total indirect lifetime costs were $140,900 per person. Scaling these costs up for the Australian population, the estimated incidence-based lifetime CVD costs for Australia were $60.5 billion ($28.2 billion in direct costs and $32.3 billion in indirect costs).

Conclusions Incidence-based lifetime indirect costs of CVD were higher than the direct costs. The life-time cost structure suggests that economic benefits of health care interventions for cardiovascular diseases from a societal perspective should be at least twice as large than that from a health service perspective.

Journal Title

Heart, Lung and Circulation

Conference Title
Book Title
Edition
Volume
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© 2021 Australasian Society of Cardiac and Thoracic Surgeons and The Cardiac Society of Australia and New Zealand. Published by Elsevier Ltd. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence (http://creativecommons.org/licenses/by-nc-nd/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, providing that the work is properly cited.

Item Access Status
Note

This publication has been entered in Griffith Research Online as an advanced online version.

Access the data
Related item(s)
Subject

Health economics

Cardiovascular medicine and haematology

Health services and systems

Public health

Persistent link to this record
Citation

Nghiem, S; Afoakwah, C; Byrnes, J; Scuffham, P, Lifetime Costs of Hospitalised Cardiovascular Disease in Australia: An Incidence-Based Estimate, Heart, Lung and Circulation, 2021

Collections